Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 225 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 225 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Potassium chloride (KCl) dissociates to K+ ions, which are essential for maintaining intracellular osmolarity, nerve impulse transmission, cardiac and skeletal muscle contraction, and acid-base balance. Dextrose 5% provides calories and may help prevent ketosis. Sodium chloride 0.225% provides sodium and chloride ions to maintain electrolyte balance.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
The typical adult dose is 10 mEq of potassium chloride (as 20 mL of 10 mEq/20 mL solution) administered intravenously at a rate not exceeding 10 mEq per hour, diluted in an appropriate IV fluid such as D5W or NS. For this product (10 mEq KCl in D5 0.225% NaCl), the entire container is infused at a rate to deliver potassium at 10 mEq/hour or slower, with continuous ECG monitoring.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Not applicable for intravenous potassium; rapid distribution and elimination with first-order kinetics; serum potassium half-life ~2-3 hours with normal renal function
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Primarily renal (90-95% excreted unchanged in urine); minimal fecal (~5%)
Category C
Category A/B
Electrolyte
Electrolyte